Sign In
Buy ANIP
$75.23
+0.580 (+0.777%)
At Close: Jun 03, 2026
Is ANI Pharmaceuticals (ANIP) Stock Undervalued Right Now?
10:46am, Friday, 31'st Jan 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
10:40am, Friday, 31'st Jan 2025
Here is how ANI Pharmaceuticals (ANIP) and CG Oncology, Inc. (CGON) have performed compared to their sector so far this year.
ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference
04:30pm, Tuesday, 28'th Jan 2025
PRINCETON, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer,
Is ANI Pharmaceuticals (ANIP) a Great Value Stock Right Now?
10:46am, Wednesday, 15'th Jan 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Alcami Announces CEO Transition
11:12am, Monday, 13'th Jan 2025
Long time industry leader, Chairman of the Board Patrick Walsh replaces CEO Bill Humphries DURHAM, N.C. , Jan. 13, 2025 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development
ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook
06:50am, Monday, 13'th Jan 2025
BAUDETTE, Minn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today affirmed its prior net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP
ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity
06:50am, Thursday, 02'nd Jan 2025
PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administratio
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
10:51am, Wednesday, 01'st Jan 2025
Here is how ANI Pharmaceuticals (ANIP) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
04:05pm, Monday, 30'th Dec 2024
PRINCETON, N.J., Dec. 30, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer;
All You Need to Know About ANI (ANIP) Rating Upgrade to Buy
01:01pm, Thursday, 26'th Dec 2024
ANI (ANIP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
10:46am, Wednesday, 18'th Dec 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
03:26pm, Monday, 02'nd Dec 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference
04:30pm, Tuesday, 26'th Nov 2024
PRINCETON, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer,
Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?
10:55am, Tuesday, 26'th Nov 2024
The consensus price target hints at a 31.3% upside potential for ANI (ANIP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revi
ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?
01:00pm, Wednesday, 20'th Nov 2024
ANI (ANIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
